slides · global inventory
All filtered slides
Global slide inventory for the active corpus filters, with each row opening the slide detail view.
Corpus coverage
319,975 slides
319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.
- Total slides
- 319,975
- Described
- 319,974
- Pending
- 1
100%ready for canon
Slide type composition
dynamicclickable
Slide type
Showing 319,974 described slides — 100.0% of 319,975 rendered pages
+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs
Tile area is proportional to slide count. Click a category to open its subtype map.
all document kinds · all orientations
Slide collection
194,161-194,220 of 319,975
19
The slide uses a timeline-based visualization to show clinical progress and pairs it with financial status.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · The Ask1 hit
20
Third Harmonic Bio | Investor Presentation Deck | 20 slidesThird Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations 1 hit
01
Includes company logo, ticker symbol, conference name, and document versioning.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations 1 hit
02
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations 1 hit
03
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
05
The slide provides a comprehensive overview of clinical and preclinical programs with detailed footnotes explaining specific drug statuses and licensing agreements.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · ProblemLoop · Golden Circle1 hit
06
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
07
The slide uses a split-layout: left side describes the drug product, right side lists clinical trial status for Fibromyalgia, Long COVID, and PTSD.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
Includes clinical trial status (RELIEF, RALLY, RESILIENT) and market demographics.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
Clinical trial design slide for Tonix Pharmaceuticals.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
Slide 10 of a corporate presentation deck.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide outlines a clinical trial protocol for TNX-102 SL in Long COVID patients.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Includes disclaimer about non-approval and patent status.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Slide 13 of a Tonix Pharmaceuticals presentation.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
Includes clinical trial status and mechanism of action highlights.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Slide provides a high-level summary of a pharmaceutical asset's profile and development roadmap.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
17
The slide uses a two-column layout to contrast the disease profile with the development program status.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
18
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · Market SizeLoop · Golden Circle1 hit
19
Includes a comparison of three generations of CD40L antibodies and a structural diagram of the antibody.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
20
The slide outlines a drug development asset in the immunology portfolio.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
21
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
22
The slide uses a split-layout design with a left-hand column for platform differentiators and a right-hand column for specific product status and next steps.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
23
The slide uses a process-like diagram to show the evolution from historical vaccines (Vaccinia, Horsepox) to a modern programmable 'Antigen Coding' platform.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
24
The slide lists three distinct facilities: RDC (Frederick, MD), ADC (North Dartmouth, MA), and CMC (Hamilton, MT).Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
25
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
26
The slide uses checkmarks for completed items and empty squares for future items.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
27
The slide uses a grid-like layout to associate logos of institutions with specific TNX drug candidates.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
28
Tonix Pharmaceuticals | Investor Presentation Deck | 29 slidesTonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · TeamLoop · Golden Circle1 hit
29
Standard corporate closing slide.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Loop · Golden Circle1 hit
01
Truist Financial Corp | Results Presentation Deck | 37 slidesTruist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · Attention1 hit
02
Truist Financial Corp | Results Presentation Deck | 37 slidesTruist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · Attention1 hit
03
Truist Financial Corp | Results Presentation Deck | 37 slidesTruist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · Attention1 hit
04
Truist Financial Corp | Results Presentation Deck | 37 slidesTruist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · Attention1 hit
05
The slide uses a five-column layout to categorize impact metrics and strategic achievements.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · Attention1 hit
06
Truist Financial Corp | Results Presentation Deck | 37 slidesTruist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
The slide provides a reconciliation of specific non-GAAP items.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
Includes both GAAP and Adjusted metrics with period-over-period comparisons.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
09
Includes footnotes defining the metrics used in the charts.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
10
HFI = Held for Investment; C&I = Commercial & Industrial; PAA = Purchase Accounting Adjustment; CRE = Commercial Real Estate; PPP = Paycheck Protection Program.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
11
The slide includes a footnote explaining the cumulative beta calculation.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
Includes breakdown of Core net interest income vs Purchase accounting accretion (PAA) and Reported NIM vs Core NIM.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
13
Includes a small data table at the bottom for 'Other income detail' and a stacked bar chart showing fee income ratio.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
The slide uses a stacked bar chart to show expense composition and overlay markers for efficiency ratios.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
15
The slide uses a consistent color palette and layout to compare credit performance metrics across time.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
16
Includes preliminary regulatory capital information.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
17
Truist Financial Corp | Results Presentation Deck | 37 slidesTruist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
18
The slide uses checkmarks to indicate the active focus areas for each year.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
19
The slide uses a stepped, ascending visual structure to represent the pillars of the investment thesis.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
20
Truist Financial Corp | Results Presentation Deck | 37 slidesTruist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
21
Includes footnotes (1) and (2) regarding data exclusions and reporting basis.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
22
Includes income statement and balance sheet data with linked quarter and like quarter changes.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
23
Includes non-GAAP reconciliation note at the bottom.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
24
The table tracks beginning balances, accretion/amortization, and ending balances across five quarters.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
25
Includes historical data and projections (marked with E).Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
26
Includes disclaimer regarding forward curve assumptions and rounding.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · ActionLoop · Hypothesis Test1 hit
27
Truist Financial Corp | Results Presentation Deck | 37 slidesTruist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · Action1 hit
28
Includes footnote (1) explaining the nature of the non-GAAP adjustments.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · Action1 hit
29
The slide provides a detailed breakdown of adjustments made to GAAP noninterest expense and revenue to arrive at an adjusted efficiency ratio.Truist Financial Corp | Results Presentation Deck | 37 slides · Truist
Conference presentation Investor relations Beat · Action1 hit